The steroid API powerhouse hits the IPO highway: Symbiotec bets ₹1,757 cr on a global pharma moat
Rosewood Investments and Motilal Oswal-backed Symbiotec Pharmalab fixes IPO price band at ₹938–₹988; public issue opens August 24 ₹1,757-crore issue ...


